News for CEL-SCI Corporation (CVM)

CEL-SCI Corporation (CVM) successfully closes its public offering of 2 million common stock shares at $2.50 each, raising $5 million in gross proceeds.The comp

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining around 0.2% on Thursday. The Dow traded up 0.17% to 41,932.94 while the NASD...

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 100 points on Thursday. Following the market opening Thursday, the D...

California-based Navitas Semiconductor Corporation (NVTS) is up over 14 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in xxday's pre-market trading.

CEL-SCI Corporation (CVM) announces the pricing of an underwritten public offering of 2 million shares at $2.50 per share. Gross proceeds expected at $5

CEL-SCI Corporation (CVM) announces a proposed public offering of common stock and/or pre-funded warrants. The offering proceeds will support the develo

CEL-SCI Corporation (CVM) submits Breakthrough Medicine Designation application for its cancer therapy, Multikine, in Saudi Arabia. The Saudi Food and D

CEL-SCI Corporation (CVM) has announced a significant development following its recent annual shareholder meeting. The company's board of directors approved a 1

CEL-SCI Corporation (CVM) announces a 1-for-30 stock combination effective May 20, 2025. The combination aims to increase the share price to attract mor

CEL-SCI Corporation (CVM) plans to file for regulatory approval of Multikine in Saudi Arabia. The company reported a net loss of $6.6 million for the fi

CEL-SCI Corporation (CVM) to file for regulatory approval of Multikine in Saudi Arabia with expected response in 60 days. Exploring partnerships for Mul

PR NewswireVANCOUVER, BC, April 14, 2025 Equity Insider News CommentaryIssued on behalf of Oncolytics Biotech Inc.VANCOUVER, BC, April 14, 2025 /PRNewswire

Shares of Harrow, Inc. HROW rose sharply in pre-market trading after the company reported fourth quarter and year-end 2024 unaudited preliminary financial resul...

U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.7% on Monday. The Dow traded down 0.67% to 42,702.02 while the NASDAQ fel...

U.S. stocks traded lower midway through trading, with the Nasdaq Composite dipping more than 100 points on Monday. The Dow traded down 0.61% to 42,725.52 while...

U.S. stocks traded lower this morning, with the Dow Jones dipping around 600 points on Monday. Following the market opening Monday, the Dow traded down 1.40% t...

U.S. stock futures declined on Monday after ending lower on Friday. All four index futures slipped in trade.

CEL-SCI Announces Pricing of $5 Million Public Offering

CEL-SCI Announces Proposed Public Offering of Common Stock